Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 29659732.
- Also identified by DOI 10.1093/cid/ciy279.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The clinical outcomes and safety of dalbavancin as primary and sequential treatment of gram-positive bacteremia with infective endocarditis were evaluated retrospectively. The clinical success rate was high (92.6%), but in 24 of 27 patients dalbavancin was used only after clearance of bacteria from the bloodstream.
Medical subject headings
- Anti-Bacterial Agents
- Endocarditis, Bacterial
- Gram-Positive Bacterial Infections
- Teicoplanin